Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Approves Boston Scientific’s SYNERGY BP Stent For High Bleeding Risk Patients

Aug 13 2020

• By Reed Miller

Sep 16, 2019 Fremont / CA / USA - Boston Scientific office buildings in Silicon Valley; Boston Scientific Corporation is a manufacturer of medical devices used in interventional medical specialties — • Source: shutterstock.com

Related Content

Boston Expects Synergy To Dominate Drug-Eluting Stents In US

Oct 07 2015

TCT 2019: Evolve Short DAPT And Model U-SUS Study Show Short DAPT Was Comparable To Longer-Term DAPT

Sep 27 2019

ACC 2020: Medtronic’s Resolute Onyx DES Meets Goals In US/Japan High Bleeding Risk Patients

Apr 09 2020

Expert Webinar Explores Pressing Questions About Biosorbable Stent Technology

Sep 21 2016

Related Companies

Boston Scientific Corporation

Additional Topics

United States Approvals Research & Development Combination Products Cardiology Medical Device

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window